Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1165]

Multiplex IHC as biomarkers for cancer immunotherapy

Dr Paul Tumeh - UCLA Medical Center, Los Angeles, USA

Multiplex IHC as biomarkers for cancer immunotherapy ( Dr Paul Tumeh - UCLA Medical Center, Los Angeles, USA )

Integrating multiple omics information in the era of precision oncology

Dr Yu Shyr - Vanderbilt-Ingram Cancer Center, Nashville, USA

Integrating multiple omics information in the era of precision oncology ( Dr Yu Shyr - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Successes and challenges in designing combination immunotherapy clinical trials...

Prof Leisha Emmens - Johns Hopkins Kimmel Cancer, Baltimore, USA

Successes and challenges in designing combination immunotherapy clinical trials for breast cancer ( Prof Leisha Emmens - Johns Hopkins Kimmel Cancer, Baltimore, USA )

Breast cancer risk prediction models improved by adding multiple biological...

Dr Xuehong Zhang - Dana-Farber Cancer Institute, Boston, USA

Breast cancer risk prediction models improved by adding multiple biological markers of risk ( Dr Xuehong Zhang - Dana-Farber Cancer Institute, Boston, USA )

Mechanisms of immune escape in non-Hodgkin lymphoma

Dr Riccardo Dalla-Favera - Columbia University Medical Center, New York, USA

Mechanisms of immune escape in non-Hodgkin lymphoma ( Dr Riccardo Dalla-Favera - Columbia University Medical Center, New York, USA )

'Helper' T Cells effective in therapy, and shows early clinical responses in...

Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA

'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer ( Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA )

Technologies for personalised cancer immunotherapies

Prof James Heath - California Institute of Technology, Pasadena, USA

Technologies for personalised cancer immunotherapies ( Prof James Heath - California Institute of Technology, Pasadena, USA )

Chronic lymphocytic leukaemia: Transition to a new era

Prof Stephen Mulligan - Royal North Shore Hospital, Australia

Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )

p62: Metabolism and the tumour microenvironment

Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La...

p62: Metabolism and the tumour microenvironment ( Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA )

Cancer cells plasticity and drug resistance

Dr Rafaella Sordella - Cold Harbor Spring Laboratory, New York, USA

Cancer cells plasticity and drug resistance ( Dr Rafaella Sordella - Cold Harbor Spring Laboratory, New York, USA )

Targeted therapy shows continued promise in patients whose tumours had NTRK...

Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA

Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions ( Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA )

Editor's Choice for April 2016

Prof Gordon McVie - ecancer Editor

Editor's Choice for April 2016 ( Prof Gordon McVie - ecancer Editor )

More from ecancer